Within a Cancer and Leukemia Group B ( CALGB ) national clinical trial of four adjuvant therapy regimens for stage II breast cancer ( CALGB 8082 ) , this study prospectively examined the contribution of potential psychological predictors to length of disease-free and overall survival over a 15-year period .
